Hands-on cardiac education pays dividends for patients and others, says Abiomed

Hands-on cardiac education pays dividends for patients and others, says Abiomed

At a Heart Recovery Advocate Day held on February 3 at Abiomed’s Danvers, Massachusetts, headquarters, patients shared their stories of heart recovery, toured the facility, participated in lab demonstrations and had the opportunity to meet the operators who made their left ventricular assist devices, right ventricular assist devices and lung-assist devices.Connecting patients with each other, and with technologists
Beyond pictures, videos and surgical explanations, many cardiology intervention patients want to know more about the technology that enabled their heart recovery. 
That is clear from the 24 survivors that experienced planned or unplanned percutaneous coronary interventions and cardiogenic shock events and who attended the largest…

Continue Reading
Regenstrief Institute names new president and CEO

Regenstrief Institute names new president and CEO

Indiana University School of Medicine this week announced that Rachel E. Patzer, an expert in epidemiology and health services research, has been appointed to be president and chief executive officer of the school-affiliated Regenstrief Institute.WHY IT MATTERSPatzer, who holds degrees including a masters in public health and a doctorate in epidemiology, will begin the new role on May 1. She currently works at Emory University School of Medicine, where she serves as the founding director of its Health Services Research Center and is a tenured professor there in the school’s department of surgery.
She founded the Health Services Research Center at Emory…

Continue Reading
New York approves AI-driven breast cancer diagnostic

New York approves AI-driven breast cancer diagnostic

With Clinical Laboratory Evaluation Program assay validation, the company’s Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples.WHY IT MATTERS
Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible.
“Consistent with our mission of improving healthcare, PDxBr has shown to be an effective prognostic tool to further improve risk stratification over current histopathology methods,” said Wayne Brinster, CEO of PreciseDx, in an announcement.
The company says the AI technology has now proven its ability to enhance invasive breast cancer pathology interpretation with objective, quantifiable and accurate…

Continue Reading
Apollo Hospitals expands access to AI decision support tool

Apollo Hospitals expands access to AI decision support tool

Doctors across India can now access an AI clinical decision support tool from Apollo Hospitals.Last year, the hospital chain launched the Apollo Clinical Intelligence Engine (CIE), a self-learning engine that analyses symptoms, determines causes, and helps recommend the best course of action. 
The technology, which is built, maintained, and periodically reviewed by an in-house team of over 500 Apollo doctors and specialists, is capable of analysing huge amounts of data – it has over 1,300 conditions and 800 symptoms in its vocabulary at present – to help identify patterns that may be otherwise missed by manual diagnoses. 
Built using four decades worth of hospital data,…

Continue Reading